한글목차

세계의 헬스케어용 아이트래킹 시장 규모는 2024년에 8억 287만 달러에 달하며, 2033년에는 51억 5,583만 달러에 달할 것으로 보이며, 2025-2033년의 예측 기간 중 CAGR 21.4%로 성장할 것으로 예측됩니다.

세계 헬스케어 분야의 아이트래킹 시장은 진단 툴에서 의료기기 및 용도의 사용자 경험 개선에 이르기까지 의료 서비스 제공의 다양한 측면을 강화하기 위해 아이트래킹 기술을 활용하고 있습니다. 아이트래킹은 사람의 눈의 움직임과 초점을 측정하여 신경학적 평가, 인지장애 진단, 재활치료에 귀중한 데이터를 제공합니다.

이 기술은 뇌졸중, 치매, 시각 장애와 같은 상태를 감지하기 위해 눈의 움직임을 모니터링하는 데 사용될 뿐만 아니라 ADHD 및 자폐 스펙트럼 장애와 같은 정신건강 상태에 대한 인사이트를 제공합니다. 환자가 어디에 어떻게 집중하는지 추적함으로써 의료 전문가는 인지 및 신경학적 건강에 대한 더 깊은 이해를 얻을 수 있으며, 보다 정확한 치료와 진단으로 이어질 수 있습니다.

신경 및 인지 장애의 유병률 증가는 전 세계 헬스케어 분야 아이트래킹 시장의 주요 촉진요인입니다. 알츠하이머병, 파킨슨병, 뇌졸중, 자폐 스펙트럼 장애(ASD)와 같은 신경 및 인지 질환이 보편화됨에 따라 아이트래킹 기술과 같은 혁신적인 진단 및 모니터링 툴에 대한 수요가 증가하고 있습니다.

아이트래킹은 눈의 움직임을 분석하여 이러한 장애에 대한 귀중한 인사이트를 제공하여 초기 징후를 식별하고 보다 정확한 진단에 도움을 줄 수 있습니다. 예를 들어 세계보건기구(WHO)의 추산에 따르면 전 세계에서 약 5,000만 명이 치매를 앓고 있으며, 그 수는 2030년까지 8,200만 명으로 증가할 것으로 예상됩니다. 또한 파킨슨병은 전 세계에서 약 1,000만 명이 앓고 있습니다. 이러한 수치는 헬스케어 분야에서 더 나은 진단 툴의 시급한 필요성을 강조하고 있습니다.

아이트래킹은 신경 기능을 평가하고, 인지 기능의 조기 변화를 감지하고, 비침습적으로 질병의 진행을 모니터링할 수 있는 비침습적 방법을 제공하는 데 중요한 역할을 할 수 있습니다. 전 세계 인구의 고령화와 인지 장애 발생률이 증가함에 따라 아이트래킹 기술은 환자 치료와 치료 결과를 개선하고자 하는 임상의에게 필수적인 툴이 되고 있습니다. 이러한 모든 요인들이 헬스케어 분야의 세계 아이트래킹 시장에 대한 수요를 창출하고 있습니다.

높은 장비 및 도입 비용으로 인해 전 세계 의료용 아이트래킹 시장은 특히 의료 환경에서 아이트래킹 기술이 널리 채택되는 것을 제한하는 주요 요인으로 작용하고 있습니다. 특히 의료 진단 및 신경학적 평가를 위해 설계된 아이트래킹 시스템은 고급 센서, 특수 소프트웨어, 고급 하드웨어 컴포넌트를 포함하는 경우가 많아 가격이 비쌉니다.

예를 들어 신경질환이나 인지 장애와 관련된 미묘한 눈의 움직임을 감지할 수 있는 임상 등급의 시스템은 장비와 이를 지원하는 인프라 모두에 많은 투자가 필요합니다. 1,001-10,000달러의 아이트래킹 시스템의 가격대는 특정 용도에 적합할 수 있지만, 고급 의료 진단에 필요한 정확도 및 신뢰성 기준을 충족하지 못할 수 있으므로 세계 의료용 아이트래킹 시장 성장의 걸림돌로 작용할 수 있습니다. 작용할 수 있습니다. 따라서 위의 요인들이 헬스케어 분야 아이트래킹 세계 시장의 잠재적 성장을 제한하는 요인으로 작용할 수 있습니다.

세계의 헬스케어용 아이트래킹 시장에 대해 조사했으며, 시장의 개요와 유형별, 트래킹 유형별, 컴포넌트별, 용도별, 최종사용자별, 지역별 동향, 경쟁 구도 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.

목차

제1장 시장의 서론과 범위

제2장 경영자 인사이트와 주요 포인트

제3장 시장 역학

• 영향요인
  • 촉진요인
  • 억제요인
  • 기회
  • 영향 분석

제4장 전략적 인사이트와 업계 전망

• 시장의 리더와 파이오니어
• CXO의 시점
• 최신 개발과 브레이크스루
• 사례 연구/진행중인 조사
• 규제와 상환의 상황
• Porter's Five Forces 분석
• 공급망 분석
• 특허 분석
• SWOT 분석
• 미충족 요구와 갭
• 시장 진출과 확대를 위한 추천 전략
• 시나리오 분석 베스트 케이스, 베이스 케이스, 워스트 케이스 예측
• 가격 분석과 가격 동향
• 주요 오피니언 리더

제5장 헬스케어용 아이트래킹 시장(유형별)

• 안전도 검사(EOG)
  • 트래킹
• 광학 추적
• 아이트래킹

제6장 헬스케어용 아이트래킹 시장(트래킹 유형별)

• 리모트 트래킹
• 모바일 트래킹

제7장 헬스케어용 아이트래킹 시장(컴포넌트별)

• 하드웨어
• 소프트웨어

제8장 헬스케어용 아이트래킹 시장(용도별)

• 의료 연구 및 진단
• 지원 기술
• 인지 & 신경학 연구
• 안과학과 시각 과학

제9장 헬스케어용 아이트래킹 시장(최종사용자별)

• 의료기관
• 연구기관
• 보조 기구 제조업체

제10장 헬스케어용 아이트래킹 시장, 지역별 시장 분석과 성장 기회

• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 스페인
  • 이탈리아
  • 기타
• 라틴아메리카
  • 브라질
  • 아르헨티나
  • 기타
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 한국
  • 기타
• 중동 및 아프리카

제11장 경쟁 구도와 시장 포지셔닝

• 경쟁 구도의 개요와 주요 시장 참여 기업
• 시장 점유율 분석과 포지셔닝 매트릭스
• 전략적 파트너십, 합병·인수
• 제품 포트폴리오와 혁신의 주요 발전
• 기업 벤치마킹

제12장 기업 개요

• Tobii
• 회사 개요
• 제품 포트폴리오
• 재무 개요
• 주요 발전
• SWOT 분석
• SR Research Ltd.
• iMotions
• Gazepoint
• EyeTech Digital Systems, Inc.
• Pupil Labs GmbH.
• EyeTracking
• Smart Eye
• Lumen
• ERGONEERS GmbH

제13장 가정과 조사 방법

제14장 부록

영문목차

The global eye tracking in healthcare market reached US$ 802.87 million in 2024 and is expected to reach US$ 5,155.83 million by 2033, growing at a CAGR of 21.4 % during the forecast period of 2025-2033.

The global eye tracking in healthcare market leverages eye tracking technology to enhance various aspects of healthcare delivery, ranging from diagnostic tools to improving the user experience in medical devices and applications. Eye tracking measures the movement and focus of a person's eyes, providing valuable data for neurological assessments, cognitive disorder diagnoses, and rehabilitation therapy.

This technology is used to monitor eye movements for the detection of conditions such as stroke, dementia, and visual impairments, while also offering insights into mental health conditions like ADHD or autism spectrum disorders. By tracking where and how patients focus, healthcare professionals gain a deeper understanding of cognitive and neurological health, leading to more precise treatments and diagnoses.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Neurological and Cognitive Disorders

The rising prevalence of neurological and cognitive disorders is a key driver in the global eye tracking in healthcare market. As neurological and cognitive conditions such as Alzheimer's disease, Parkinson's disease, stroke, and autism spectrum disorders (ASD) become more common, the demand for innovative diagnostic and monitoring tools, such as eye tracking technology, is increasing.

Eye tracking offers valuable insights into these disorders by analyzing eye movements, helping to identify early signs and aiding in more accurate diagnoses. For instance, the World Health Organization estimates that approximately 50 million people worldwide suffer from dementia, and the number is expected to rise to 82 million by 2030. Additionally, Parkinson's disease affects about 10 million people globally. These numbers underscore the urgent need for better diagnostic tools in the healthcare sector.

Eye tracking can play a critical role in assessing neurological function, detecting early changes in cognition, and offering a non-invasive way to monitor disease progression over time. As the global population ages and the incidence of cognitive disorders increases, eye tracking technology is becoming an essential tool for clinicians aiming to improve patient care and enhance treatment outcomes. All these factors demand global eye tracking in the healthcare market.

High Costs of Equipment and Implementation

The high costs of equipment and implementation pose a significant restraint in the global eye tracking in healthcare market, limiting the widespread adoption of this technology, especially in healthcare settings. Eye tracking systems, particularly those designed for medical diagnostics or neurological assessments, often involve high-end sensors, specialized software, and advanced hardware components that come at a steep price.

For instance, clinical-grade systems capable of detecting subtle eye movements associated with neurological diseases or cognitive disorders require significant investment in both equipment and the infrastructure to support them. The price range of $1.001 to $10,000 for eye tracking systems can act as a restraint in the global eye tracking in healthcare market because these systems, while suitable for certain applications, may not meet the precision and reliability standards required for more advanced healthcare diagnostics. Thus, the above factors could be limiting the global eye tracking in the healthcare market's potential growth.

Segment Analysis

The global eye tracking in healthcare market is segmented based on type, tracking type, component, application, end-user, and region.

Tracking Type:

The remote tracking segment in tracking type is expected to dominate the global eye tracking in healthcare market with the highest market share

The remote tracking segment of the global eye tracking in healthcare market leverages innovative technologies such as cloud computing, mobile devices, and wearable technologies to enable the monitoring of patients' eye movements outside traditional clinical settings.

This capability is crucial in telemedicine platforms, mobile health apps, and home-based monitoring systems. By allowing healthcare providers to track patients from a distance, remote eye tracking can be especially beneficial for continuous monitoring of those with neurological conditions, cognitive disorders, or individuals undergoing rehabilitation therapies.

It eliminates the need for patients to visit healthcare facilities regularly, improving access to care and enhancing patient convenience. This is especially important as patients, particularly those with chronic conditions, can experience fluctuations in symptoms that require consistent tracking.

By enabling eye movement analysis outside of medical environments, remote tracking technology offers greater flexibility in patient care and supports early detection of changes in cognitive or neurological health. It also allows for real-time data collection, making it easier to adjust treatment plans or interventions based on immediate insights. These factors have solidified the segment's position in the global eye tracking in healthcare market.

Geographical Analysis

North America is expected to hold a significant position in the global eye tracking in healthcare market, with the highest market share

The North American eye tracking in healthcare market is being driven by several factors. One of the key drivers is the increasing application of eye tracking technology in the healthcare sector, particularly for diagnosing and monitoring neurological disorders like Parkinson's disease, Alzheimer's, and other cognitive impairments. This technology provides valuable insights into eye movements and gaze patterns, which help in early detection and assessment, enhancing the effectiveness of treatment and rehabilitation.

Furthermore, North America's advanced healthcare system and technological infrastructure play a significant role in driving the market. The region is home to leading research institutions and healthcare providers that integrate eye tracking into clinical practices, such as in cognitive rehabilitation and assistive devices for patients with severe motor disabilities.

The region is also seeing increased adoption in consumer electronics, gaming, and the automotive industry, all of which are contributing to the broader use of eye tracking in healthcare settings. Thus, the above factors are consolidating the region's position as a dominant force in the global eye tracking in healthcare market.

Competitive Landscape

The major global players in the eye tracking in healthcare market include Tobii, SR Research Ltd., iMotions, Gazepoint, EyeTech Digital Systems, Inc., Pupil Labs GmbH, EyeTracking, Smart Eye, Lumen, and ERGONEERS GmbH, among others.

Key Developments

• In February 2024, Visage Imaging, Inc. unveiled the innovative Visage Ease VP for Apple Vision Pro, Apple's much-awaited spatial computing platform. Tailored to leverage the distinct features of Apple Vision Pro, Visage Ease VP enables immersive, spatial interactions for diagnostic imaging and multimedia applications.
• In January 2024, Tobii's launch of the UX Explore cloud platform, designed to enhance mobile user experience (UX) research with eye-tracking technology, is a significant development that could positively impact the global eye-tracking in healthcare market. This cloud-based solution allows for more scalable, efficient, and accessible UX research, enabling healthcare professionals and developers to evaluate the user experience of mobile healthcare applications, telemedicine platforms, and digital health devices with greater ease.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzed product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global eye tracking in healthcare market report delivers a detailed analysis with 78 key tables, more than 71 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

• 1.1. Objectives of the Report
• 1.2. Report Coverage & Definitions
• 1.3. Report Scope

2. Executive Insights and Key Takeaways

• 2.1. Market Highlights and Strategic Takeaways
• 2.2. Key Trends and Future Projections
• 2.3. Snippet by Type
• 2.4. Snippet by Tracking Type
• 2.5. Snippet by Component
• 2.6. Snippet by Application
• 2.7. Snippet by End-User
• 2.8. Snippet by Region

3. Dynamics

• 3.1. Impacting Factors
  • 3.1.1. Drivers
    • 3.1.1.1. Rising Prevalence of Neurological and Cognitive Disorders
    • 3.1.1.2. Advancements in Eye Tracking Technology
  • 3.1.2. Restraints
    • 3.1.2.1. High Costs of Equipment and Implementation
    • 3.1.2.2. Privacy and Data Security Concerns
  • 3.1.3. Opportunity
    • 3.1.3.1. Integration with Virtual Reality (VR) and Augmented Reality (AR)
  • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

• 4.1. Market Leaders and Pioneers
  • 4.1.1. Emerging Pioneers and Prominent Players
  • 4.1.2. Established leaders with the largest-selling Brand
  • 4.1.3. Market leaders with established Product
• 4.2. CXO Perspectives
• 4.3. Latest Developments and Breakthroughs
• 4.4. Case Studies/Ongoing Research
• 4.5. Regulatory and Reimbursement Landscape
  • 4.5.1. North America
  • 4.5.2. Europe
  • 4.5.3. Asia Pacific
  • 4.5.4. Latin America
  • 4.5.5. Middle East & Africa
• 4.6. Porter's Five Forces Analysis
• 4.7. Supply Chain Analysis
• 4.8. Patent Analysis
• 4.9. SWOT Analysis
• 4.10. Unmet Needs and Gaps
• 4.11. Recommended Strategies for Market Entry and Expansion
• 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 4.13. Pricing Analysis and Price Dynamics
• 4.14. Key Opinion Leaders

5. Eye Tracking in Healthcare Market, By Type

• 5.1. Introduction
  • 5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
  • 5.1.2. Market Attractiveness Index, By Type
• 5.2. Electrooculography (EOG)*
  • 5.2.1. Introduction
  • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.2.3. Tracking
• 5.3. Optical Tracking
• 5.4. Eye-Attached Tracking

6. Eye Tracking in Healthcare Market, By Tracking Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
  • 6.1.2. Market Attractiveness Index, By Tracking Type
• 6.2. Remote Tracking*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Mobile Tracking

7. Eye Tracking in Healthcare Market, By Component

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 7.1.2. Market Attractiveness Index, By Component
• 7.2. Hardware*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Software

8. Eye Tracking in Healthcare Market, By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Medical Research & Diagnostics*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Assistive Technology
• 8.4. Cognitive & Neurological Studies
• 8.5. Ophthalmology & Vision Science

9. Eye Tracking in Healthcare Market, By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Healthcare Providers*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Research Institutes
• 9.4. Assistive Device Manufacturers

10. Eye Tracking in Healthcare Market, By Regional Market Analysis and Growth Opportunities

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.8.1. U.S.
    • 10.2.8.2. Canada
    • 10.2.8.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.8.1. Germany
    • 10.3.8.2. U.K.
    • 10.3.8.3. France
    • 10.3.8.4. Spain
    • 10.3.8.5. Italy
    • 10.3.8.6. Rest of Europe
• 10.4. Latin America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.8.1. Brazil
    • 10.4.8.2. Argentina
    • 10.4.8.3. Rest of Latin America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.8.1. China
    • 10.5.8.2. India
    • 10.5.8.3. Japan
    • 10.5.8.4. South Korea
    • 10.5.8.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape and Market Positioning

• 11.1. Competitive Overview and Key Market Players
• 11.2. Market Share Analysis and Positioning Matrix
• 11.3. Strategic Partnerships, Mergers & Acquisitions
• 11.4. Key Developments in Product Portfolios and Innovations
• 11.5. Company Benchmarking

12. Company Profiles

• 12.1. Tobii*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio
    • 12.1.2.1. Product Description
    • 12.1.2.2. Product Key Performance Indicators (KPIs)
    • 12.1.2.3. Historic and Forecasted Product Sales
    • 12.1.2.4. Product Sales Volume
  • 12.1.3. Financial Overview
    • 12.1.3.1. Company Revenue
    • 12.1.3.2. Geographical Revenue Shares
    • 12.1.3.3. Revenue Forecasts
  • 12.1.4. Key Developments
    • 12.1.4.1. Mergers & Acquisitions
    • 12.1.4.2. Key Product Development Activities
    • 12.1.4.3. Regulatory Approvals, etc.
  • 12.1.5. SWOT Analysis
• 12.2. SR Research Ltd.
• 12.3. iMotions
• 12.4. Gazepoint
• 12.5. EyeTech Digital Systems, Inc.
• 12.6. Pupil Labs GmbH.
• 12.7. EyeTracking
• 12.8. Smart Eye
• 12.9. Lumen
• 12.10. ERGONEERS GmbH

LIST NOT EXHAUSTIVE

13. Assumptions and Research Methodology

• 13.1. Data Collection Methods
• 13.2. Data Triangulation
• 13.3. Forecasting Techniques
• 13.4. Data Verification and Validation

14. Appendix

• 14.1. About Us and Services
• 14.2. Contact Us